1. Home
  2. REKR vs IXHL Comparison

REKR vs IXHL Comparison

Compare REKR & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rekor Systems Inc.

REKR

Rekor Systems Inc.

N/A

Current Price

$0.41

Market Cap

41.7M

ML Signal

N/A

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

N/A

Current Price

$2.53

Market Cap

35.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
REKR
IXHL
Founded
2017
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
41.7M
35.4M
IPO Year
2017
2024

Fundamental Metrics

Financial Performance
Metric
REKR
IXHL
Price
$0.41
$2.53
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 2.0M
50.7K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 4.35
N/A
EPS
★ N/A
N/A
Revenue
★ $9,234,000.00
$12,000.00
Revenue This Year
$5.38
N/A
Revenue Next Year
$16.68
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.22
$0.16
52 Week High
$2.60
$6.39

Technical Indicators

Market Signals
Indicator
REKR
IXHL
Relative Strength Index (RSI) 57.48 30.21
Support Level $0.30 $2.52
Resistance Level $0.48 $3.89
Average True Range (ATR) 0.04 0.13
MACD 0.01 -0.01
Stochastic Oscillator 75.53 12.23

Price Performance

Historical Comparison
REKR
IXHL

About REKR Rekor Systems Inc.

Rekor Systems Inc is a roadway intelligence company focused on modernizing public safety, urban mobility, and transportation management through solutions. The company delivers services and solutions that collect, connect, and organize mobility data, providing real-time insights to support decision making, enhance situational awareness, enable rapid response, and support predictive analytics. The Company derives its revenues mainly from the licensing and sale of its roadway data and traffic management product and service offerings. These offerings include a mixture of data collection, implementation, engineering, customer support, and maintenance services, as well as software and hardware. The company operates in the United States and other regions.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical-stage biopharmaceutical development company dedicated to developing inventive medicines for patients living with serious chronic diseases and unmet needs. The Company's drug candidates include IHL-42X for the treatment of obstructive sleep apnea (OSA) and PSX-001, the Company's psilocybin treatment in combination with psychological therapy in development to treat patients with generalized anxiety disorder (GAD). The Company also has a drug candidate, IHL-675A, for the treatment of rheumatoid arthritis. Each of these programs target conditions that currently have limited, inadequate, or no approved pharmaceutical treatment options. The Company continues to evaluate strategies for IHL-675A when and as resources permit.

Share on Social Networks: